Global, phase IIb, multicentre, double-blind, double-dummy, four-arm, parallel, active comparator controlled trial of rostafuroxin capsules versus losartan in Caucasian and Chinese patients with hypertension

Trial Profile

Global, phase IIb, multicentre, double-blind, double-dummy, four-arm, parallel, active comparator controlled trial of rostafuroxin capsules versus losartan in Caucasian and Chinese patients with hypertension

Recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Dec 2015

At a glance

  • Drugs Rostafuroxin (Primary) ; Losartan
  • Indications Hypertension
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 22 Dec 2015 According to a Lee's Pharmaceutical Holdings media release, enrollment has been completed in Italy in November 2015 and the first patient from Taiwan has been enrolled on 18 December 2015. The company expects to complete enrollment in Taiwan in June 2016.
    • 12 Jun 2013 Status changed from planning to recruiting, according to a Lee's Pharmaceutical Holdings media release. The first patient has been enrolled.
    • 13 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top